OWC Pharmaceutical Research Corp (OWCP)

[EasternTimeZone]

The $5 Million investment by an Institutional Investor was on April 30, 2018 so that will be covered in Q2, because it happened in Q2. This Quarterly report we just got today is for Q1. That's how it works in the corporate world.

And what a great deal this is for OWCP. $5 Million for 25M shares, plus warrant to purchase another 12,500,000 shares for $5 Million.

So it's actually $10 Million for 37,500,000 shares common stock if the Warrants are exercised.

That's a sweet deal!

On April 30, 2018, OWC Pharmaceutical Research Corp. (the “Registrant”) entered into and consummated a Securities Purchase Agreement (the “Agreement”) with a non-US-based institutional investor (the “Purchaser”). Under the terms and conditions of the Agreement, the Registrant sold and the Purchaser bought, (i) 500 shares of the Registrant’s new series of preferred stock designated as Series A Preferred Stock (the “Preferred Shares”), which are currently convertible into 25,000,000 shares of the Registrant’s common stock, par value $0.00001 per share (“Common Stock”) and (ii) Warrants (the “Warrants”) representing the right to acquire 12,500,000 shares of Common Stock (which shall be adjusted in accordance with the terms and conditions set forth in the Certificate of Designations and the Warrants) for an aggregate purchase price of $5,000,000. Newbridge Securities Corporation, through LifeTech Capital, acted as exclusive placement agent for the transaction.

$OWCP

BIG RUN COMING



...tick tock